HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination.

Abstract
Cell migration underlies metastatic dissemination of cancer cells, and fast "amoeboid" migration in the invasive fronts of tumors is controlled by high levels of actomyosin contractility. How amoeboid migration is regulated by extracellular signals and sustained over time by transcriptional changes is not fully understood. Transforming growth factor β (TGF-β) is well known to promote epithelial-to-mesenchymal transition (EMT) and contribute to metastasis, but melanocytes are neural crest derivatives that have undergone EMT during embryonic development. Surprisingly, we find that in melanoma, TGF-β promotes amoeboid features such as cell rounding, membrane blebbing, high levels of contractility, and increased invasion. Using genome-wide transcriptomics, we find that amoeboid melanoma cells are enriched in a TGF-β-driven signature. We observe that downstream of TGF-β, SMAD2 and its adaptor CITED1 control amoeboid behavior by regulating the expression of key genes that activate contractile forces. Moreover, CITED1 is highly upregulated during melanoma progression, and its high expression is associated with poor prognosis. CITED1 is coupled to a contractile-rounded, amoeboid phenotype in a panel of 16 melanoma cell lines, in mouse melanoma xenografts, and in 47 human melanoma patients. Its expression is also enriched in the invasive fronts of lesions. Functionally, we show how the TGF-β-SMAD2-CITED1 axis promotes different steps associated with progression: melanoma detachment from keratinocytes, 2D and 3D migration, attachment to endothelial cells, and in vivo lung metastatic initial colonization and outgrowth. We propose a novel mechanism by which TGF-β-induced transcription sustains actomyosin force in melanoma cells and thereby promotes melanoma progression independently of EMT.
AuthorsGaia Cantelli, Jose L Orgaz, Irene Rodriguez-Hernandez, Panagiotis Karagiannis, Oscar Maiques, Xavier Matias-Guiu, Frank O Nestle, Rosa M Marti, Sophia N Karagiannis, Victoria Sanz-Moreno
JournalCurrent biology : CB (Curr Biol) Vol. 25 Issue 22 Pg. 2899-914 (Nov 16 2015) ISSN: 1879-0445 [Electronic] England
PMID26526369 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • Apoptosis Regulatory Proteins
  • CITED1 protein, human
  • Nuclear Proteins
  • Smad2 Protein
  • Trans-Activators
  • Transcription Factors
  • Transforming Growth Factor beta
  • Actomyosin
Topics
  • Actomyosin (metabolism)
  • Animals
  • Apoptosis Regulatory Proteins
  • Cell Line, Tumor
  • Cell Movement (genetics, physiology)
  • Cell Shape (physiology)
  • Epithelial-Mesenchymal Transition
  • Humans
  • Keratinocytes (metabolism)
  • Melanocytes (metabolism, pathology)
  • Melanoma (genetics, metabolism, pathology)
  • Mice
  • Mice, Nude
  • Neoplasm Metastasis
  • Nuclear Proteins (metabolism)
  • Smad2 Protein (metabolism)
  • Trans-Activators
  • Transcription Factors (metabolism)
  • Transcriptional Activation
  • Transforming Growth Factor beta (genetics, metabolism, pharmacology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: